Literature DB >> 2969374

Candida albicans C3d receptor, isolated by using a monoclonal antibody.

L Linehan1, E Wadsworth, R Calderone.   

Abstract

Pseudohyphae of Candida albicans possess a receptor for C3d, a fragment of the complement component C3. This receptor was partially purified by using a monoclonal antibody (CA-A) that previously had been shown to inhibit the binding of C3d to C. albicans pseudohyphae. Purified immunoglobulin G from ascites fluid (CA-A) was coupled to a cyanogen bromide-activated Sepharose column, and an affinity-purified fraction (A2) from C. albicans pseudohyphae was obtained. This fraction inhibited rosetting of the EAC3d receptor by pseudohyphae and appeared to contain glycoprotein, since receptor activity could be removed when A2 was incubated with lectins specific for mannose and glucose. A2 was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and two polypeptides of approximately 60 and 70 kilodaltons (kDa) were consistently identified in reducing gels. The 60-kDa protein was identified as a glycoprotein by concanavalin A binding. A2 was further analyzed by high-pressure liquid chromatography (HPLC). Of three fractions obtained by HPLC, one containing the 60-kDa protein was found to have receptor activity. When analyzed by HPLC, this protein was found to contain mannose and glucose in approximately equal amounts. Both immunofluorescence and electron microscopy of pseudohyphae treated with CA-A identified A2 as a surface moiety. Thus, the C3d receptor of C. albicans, isolated with CA-A, is a glycoprotein of approximately 60 kDa.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2969374      PMCID: PMC259511          DOI: 10.1128/iai.56.8.1981-1986.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Identification of concanavalin A-binding proteins after sodium dodecyl sulfate--gel electrophoresis and protein blotting.

Authors:  R Hawkes
Journal:  Anal Biochem       Date:  1982-06       Impact factor: 3.365

4.  The identification of N-linked oligosaccharides on the human CR2/Epstein-Barr virus receptor and their function in receptor metabolism, plasma membrane expression, and ligand binding.

Authors:  J J Weis; D T Fearon
Journal:  J Biol Chem       Date:  1985-11-05       Impact factor: 5.157

5.  Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.

Authors:  J J Weis; T F Tedder; D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

6.  Characterization of cerulenin-resistant mutants of Candida albicans.

Authors:  K A Hoberg; R L Cihlar; R A Calderone
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

Review 7.  Adherence of Candida species to host tissues and plastic surfaces.

Authors:  D Rotrosen; R A Calderone; J E Edwards
Journal:  Rev Infect Dis       Date:  1986 Jan-Feb

8.  Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor-specific antibody.

Authors:  J D Lambris; N J Dobson; G D Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

9.  Inducible proteinase of Candida albicans in diagnostic serology and in the pathogenesis of systemic candidosis.

Authors:  F Macdonald; F C Odds
Journal:  J Med Microbiol       Date:  1980-08       Impact factor: 2.472

View more
  30 in total

Review 1.  Cytological immunodetection of yeast glycoprotein secretion.

Authors:  J C Cailliez; D Poulain; D W Mackenzie; L Polonelli
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

2.  Characterization of cell wall proteins from yeast and mycelial cells of Candida albicans by labelling with biotin: comparison with other techniques.

Authors:  M Casanova; J L Lopez-Ribot; J P Martinez; R Sentandreu
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

Review 3.  Adherence and receptor relationships of Candida albicans.

Authors:  R A Calderone; P C Braun
Journal:  Microbiol Rev       Date:  1991-03

Review 4.  High-frequency switching in Candida albicans.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

Review 5.  Cell wall and secreted proteins of Candida albicans: identification, function, and expression.

Authors:  W L Chaffin; J L López-Ribot; M Casanova; D Gozalbo; J P Martínez
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

6.  A monoclonal antibody that defines a surface antigen on Candida albicans hyphae cross-reacts with yeast cell protoplasts.

Authors:  M W Ollert; R A Calderone
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

7.  Complex interaction between different proteinaceous components within the cell-wall structure of Candida albicans.

Authors:  J L Lopez-Ribot; D A Cortlandt; D C Straus; K J Morrow; W L Chaffin
Journal:  Mycopathologia       Date:  1995-11       Impact factor: 2.574

8.  Antigen-specific cytolysis of infected cells in murine candidiasis.

Authors:  L Romani; S Mocci; E Cenci; A Mencacci; G Sbaraglia; P Puccetti; F Bistoni
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

9.  Cell extracts of Candida albicans block adherence of the organisms to endothelial cells.

Authors:  J E Edwards; C L Mayer; S G Filler; E Wadsworth; R A Calderone
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

10.  Analysis of mannoproteins from blastoconidia and hyphae of Candida albicans with a common epitope recognized by anti-complement receptor type 2 antibodies.

Authors:  E Wadsworth; S C Prasad; R Calderone
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.